5-hydroxymethylcytosine has been researched along with Skin Neoplasms in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 17 (85.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boudra, R; Lian, CG; Ramsey, MR; Schmults, CD; Wang, D; Wells, M; Woappi, Y; Xu, S | 1 |
| Balzer, BL; Frishberg, DP; Shon, W; Yagi, S | 1 |
| Cavalcante, RG; D'Silva, NJ; de Medeiros, MC; Fernandez, EM; Figueroa, ME; Liu, S; Qin, T; Rozek, LS; Sartor, MA; Wolf, GT; Zarins, KR | 1 |
| Li, X; Lian, CG; Liu, F; Liu, X; Qiu, L; Tu, P; Wang, Y; Xiao, C; Yi, S | 1 |
| Andrews, CA; Chan, MP; Kahana, A; Rao, RC | 1 |
| Bizet, M; Bonvin, E; Calonne, E; Fuks, F; Larue, L; Luciani, F; Marine, JC; Nittner, D; Petit, V; Putmans, P; Radaelli, E; Santagostino, SF; Singh, NK | 1 |
| Balzer, BL; Essner, R; Frishberg, DP; Huynh, CAT; Shon, W; Siref, AB | 1 |
| Becker, JC; Dreibigacker, M; Gambichler, T; Rüddel, I; Schmitt, K; Stockfleth, E | 1 |
| Urso, C | 1 |
| Gambichler, T; Sand, M; Skrygan, M | 1 |
| Ashida, A; Hayashi, K; Kiniwa, Y; Koga, H; Ogawa, E; Okuyama, R; Takazawa, Y; Uchiyama, A; Uchiyama, R; Uhara, H | 1 |
| Dresser, KA; Larson, AR; Lezcano, C; Lian, CG; Mihm, MC; Murphy, GF; Scolyer, RA; Shi, YG; Thompson, JF; Woda, BA; Yosufi, B; Zhan, Q | 1 |
| Granter, SR; Guo, W; Laga, AC; Lee, JJ; Lian, CG; Murphy, GF; Saavedra, AP; Xu, S; Zhan, Q | 1 |
| Mikoshiba, Y; Ogawa, E; Okuyama, R; Uchiyama, A; Uchiyama, R; Uhara, H | 1 |
| Burghart, DR; De Souza, A; Kempf, W; Pfaltz, M; Tinguely, M | 1 |
| Burns, KH; Rodić, N; Sharma, R; Taube, JM; Zampella, J | 1 |
| Cook, M; Lee, JJ; Lian, CG; Mihm, MC; Murphy, GF; Wang, TJ; Xu, S; Zhan, Q | 1 |
| Fraitag, S; Hohl, D; Pavlova, O | 1 |
| Bamford, M; Joshi, K; Lawes, K; Moosa, F; Pringle, JH; Saldanha, G; Teo, KW | 1 |
| Bresler, SC; Fletcher, CD; Frank, AH; Granter, SR; Hu, NR; Lee, JJ; Lian, CG; Mihm, MC; Murphy, GF; Saw, RP; Scolyer, RA; Vilain, RE; Xu, S | 1 |
20 other study(ies) available for 5-hydroxymethylcytosine and Skin Neoplasms
| Article | Year |
|---|---|
Regulation of 5-Hydroxymethylcytosine by TET2 Contributes to Squamous Cell Carcinoma Tumorigenesis.
Topics: 5-Methylcytosine; Animals; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Humans; Mice; Proto-Oncogene Proteins; Skin Neoplasms | 2022 |
Epigenetic marker expression is of limited diagnostic utility in spitzoid melanocytic neoplasms.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Diagnosis, Differential; Epigenesis, Genetic; Female; Humans; Male; Melanoma; Nevus, Epithelioid and Spindle Cell; Skin Neoplasms | 2020 |
5-Hydroxymethylation highlights the heterogeneity in keratinization and cell junctions in head and neck cancers.
Topics: 5-Methylcytosine; Cell Movement; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Head and Neck Neoplasms; Humans; Intercellular Junctions; Keratinocytes; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck | 2020 |
Loss of 5-Hydroxymethylcytosine Is an Epigenetic Biomarker in Cutaneous T-Cell Lymphoma.
Topics: 5-Methylcytosine; Apoptosis; Biomarkers, Tumor; Carcinogenesis; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Disease Progression; Epigenesis, Genetic; Female; Humans; Keratinocytes; Lymphoma, T-Cell, Cutaneous; Male; Mycosis Fungoides; Neoplasm Staging; Prognosis; Skin Neoplasms; Survival Analysis | 2018 |
Epigenetic markers in basal cell carcinoma: universal themes in oncogenesis and tumor stratification? - a short report.
Topics: 5-Methylcytosine; Carcinogenesis; Carcinoma, Basal Cell; Epigenesis, Genetic; Histones; Humans; Lysine; Methylation; Skin Neoplasms | 2018 |
TET2-Dependent Hydroxymethylome Plasticity Reduces Melanoma Initiation and Progression.
Topics: 5-Methylcytosine; Animals; Dioxygenases; Disease Progression; DNA-Binding Proteins; DNA, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Mice, Transgenic; Monomeric GTP-Binding Proteins; Proto-Oncogene Proteins; Rats; Skin Neoplasms | 2019 |
Diagnostic utility of dual 5-hydroxymethylcytosine/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the workup of sentinel lymph node specimen.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Diagnosis, Differential; Humans; Immunohistochemistry; Lymphatic Metastasis; MART-1 Antigen; Melanoma; Melanoma, Cutaneous Malignant; Nevus, Pigmented; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Skin Neoplasms; Staining and Labeling | 2019 |
Decreased 5-hydroxymethylcytosine immunoreactivity in primary Merkel cell carcinoma is a strong predictor for disease-specific death.
Topics: 5-Methylcytosine; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Merkel Cell; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Female; Follow-Up Studies; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Male; Merkel cell polyomavirus; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prognosis; Proto-Oncogene Proteins; Sex Factors; Skin; Skin Neoplasms; Viral Load | 2019 |
Certain and uncertain malignant potential in melanocytic skin neoplasms.
Topics: 5-Methylcytosine; Biomarkers; Humans; Nevus, Pigmented; Skin Neoplasms | 2019 |
Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Cytosine; Dioxygenases; Disease Progression; DNA-Binding Proteins; Epigenomics; Humans; Melanoma; Paraffin Embedding; Proto-Oncogene Proteins; Skin Neoplasms; Translocation, Genetic | 2013 |
5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers; CpG Islands; Cytosine; DNA Methylation; Epigenesis, Genetic; Female; Humans; Keratinocytes; Male; Melanoma; Middle Aged; Nevus, Epithelioid and Spindle Cell; Nevus, Pigmented; Skin Neoplasms | 2014 |
Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Cytosine; DNA Methylation; Female; Humans; Male; Melanoma; Middle Aged; Nevus; Precancerous Conditions; Skin Neoplasms; Young Adult | 2014 |
5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cytosine; Female; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nevus; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2015 |
5-Hydroxymethylcytosine is a useful marker to differentiate between dermatofibrosarcoma protuberans and dermatofibroma.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Cytosine; Dermatofibrosarcoma; Humans; Skin Neoplasms | 2016 |
Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.
Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Case-Control Studies; Child; Cytosine; Epigenesis, Genetic; Female; Humans; Immunohistochemistry; Ki-1 Antigen; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Lymphomatoid Papulosis; Male; Middle Aged; Retrospective Studies; Skin Neoplasms; Young Adult | 2014 |
Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations.
Topics: 5-Methylcytosine; Cytosine; Diagnosis, Differential; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Melanocytes; Melanoma; Nevus, Pigmented; Skin Neoplasms; Tissue Array Analysis | 2015 |
Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma.
Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Small Cell; Cytosine; Epigenomics; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Staging; Nevus, Pigmented; Prognosis; Skin Neoplasms; Young Adult | 2015 |
5-Hydroxymethylcytosine Expression in Proliferative Nodules Arising within Congenital Nevi Allows Differentiation from Malignant Melanoma.
Topics: 5-Methylcytosine; Adult; Analysis of Variance; Biopsy, Needle; Cohort Studies; Diagnosis, Differential; Disease Progression; Dysplastic Nevus Syndrome; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Melanoma; Melanoma, Cutaneous Malignant; Nevus, Pigmented; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Retrospective Studies; Skin Neoplasms | 2016 |
5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanoma.
Topics: 5-Methylcytosine; Age Factors; Aged; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Skin; Skin Neoplasms; Survival Rate | 2017 |
5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cohort Studies; Female; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Male; Melanoma; Middle Aged; Nevus, Pigmented; Retrospective Studies; Skin Neoplasms; Young Adult | 2017 |